MOLECULAR PARTNERS AG MOLN
ADS · ADR · CUSIP 60853G106
Biopharmaceutical company based in Zürich, Switzerland
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersSchlieren, Switzerland
- Founded2004
- Websitemolecularpartners.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $3.84.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 9 |
| Q4 2022 | 9 |
| Q1 2023 | 7 |
| Q2 2023 | 8 |
| Q3 2023 | 8 |
| Q4 2023 | 9 |
| Q1 2024 | 9 |
| Q2 2024 | 9 |
| Q3 2024 | 6 |
| Q4 2024 | 6 |
| Q1 2025 | 7 |
| Q2 2025 | 7 |
| Q3 2025 | 6 |
| Q4 2025 | 6 |
| Q1 2026 | 4 |
| Q2 2026 | 5 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 2 | 3 |
| Q4 2024 | 3 | 1 |
| Q1 2025 | 1 | 1 |
| Q2 2025 | 2 | 1 |
| Q3 2025 | 1 | 1 |
| Q4 2025 | 0 | 3 |
| Q1 2026 | 1 | 2 |
| Q2 2026 | 2 | 1 |
Biggest buyers
| CITADEL ADVISORS LLC | New | +17.2k |
| UBS Group AG | New | +279 |
Biggest sellers
| SmartHarvest Portfolios, LLC | Sold out | -15.5k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC 13G · passive investor new · filed 2025-05-02 | 10.6% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME 13G · institution new · filed 2025-07-17 | 5.8% |
Insider purchases and sales since 1 Apr 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported since 1 Apr 2026.
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| MONTANOVA CAPITAL, LLC 0.18% of their portfolio | 2.2m $8.6m | Unchanged |
| BVF INC/IL 0.13% of their portfolio | 1.4m $5.1m | Unchanged |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 17.2k $65.3k | New |
| MORGAN STANLEY 0.00% of their portfolio | 367 $1.4k | Unchanged |
| UBS Group AG 0.00% of their portfolio | 279 $1.1k | New |